Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lannett Co. Inc (LCI)

Lannett Co. Inc (LCI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 348,898
  • Shares Outstanding, K 40,335
  • Annual Sales, $ 655,410 K
  • Annual Income, $ -272,110 K
  • 60-Month Beta 2.15
  • Price/Sales 0.55
  • Price/Cash Flow 2.36
  • Price/Book 1.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.27
  • Number of Estimates 3
  • High Estimate 0.29
  • Low Estimate 0.23
  • Prior Year 0.86
  • Growth Rate Est. (year over year) -68.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.16 +4.04%
on 12/05/19
12.72 -33.25%
on 11/06/19
-3.81 (-30.98%)
since 11/05/19
3-Month
8.16 +4.04%
on 12/05/19
15.52 -45.30%
on 09/13/19
-2.93 (-25.66%)
since 09/05/19
52-Week
4.33 +96.07%
on 12/26/18
15.52 -45.30%
on 09/13/19
+3.00 (+54.64%)
since 12/04/18

Most Recent Stories

More News
Look for Shares of Lannett Co Inc to Potentially Rebound after Yesterday's 2.29% Sell Off

Lannett Co Inc (NYSE:LCI) traded in a range yesterday that spanned from a low of $8.41 to a high of $9.78. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $8.43 on...

LCI : 8.49 (-1.85%)
Lannett Announces Positive Results From Human Clinical Trial Of Biosimilar Insulin Glargine Versus US Lantus®

Lannett Company, Inc. (NYSE: LCI) today announced positive results from the first human study evaluating insulin glargine that Lannett is developing with its strategic alliance partners within the HEC...

LCI : 8.49 (-1.85%)
17.2% Return Seen to Date on SmarTrend Lannett Co Inc Call (LCI)

SmarTrend identified a Downtrend for Lannett Co Inc (NYSE:LCI) on October 14th, 2019 at $10.80. In approximately 1 month, Lannett Co Inc has returned 17.22% as of today's recent price of $8.94.

LCI : 8.49 (-1.85%)
Shares of Zogenix Inc Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (ZGNX , RVNC , LCI , MYL , PRGO )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

LCI : 8.49 (-1.85%)
RVNC : 15.93 (-4.09%)
ZGNX : 45.58 (-2.59%)
Lannett Co Inc Falls 13.31% on Heavy Volume: Watch For Potential Rebound

Lannett Co Inc (NYSE:LCI) traded in a range yesterday that spanned from a low of $9.32 to a high of $10.05. Yesterday, the shares fell 13.3%, which took the trading range below the 3-day low of $9.60...

LCI : 8.49 (-1.85%)
Dermira has the Best Relative Performance in the Pharmaceuticals Industry (DERM , LLY , LCI , BMY , ZTS )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

DERM : 7.89 (-1.62%)
LLY : 119.77 (+0.93%)
LCI : 8.49 (-1.85%)
Lannett (LCI) Beats Q1 Earnings and Revenue Estimates

Lannett (LCI) delivered earnings and revenue surprises of 10.00% and 4.88%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

LCI : 8.49 (-1.85%)
Lannett Announces Fiscal 2020 First-Quarter Financial Results

Financial and Business Highlights:

LCI : 8.49 (-1.85%)
Prothena (PRTA) Reports Narrower-than-Expected Loss in Q3

Prothena (PRTA) posts a narrower Q3 loss while sales surpass estimates.

RHHBY : 38.4300 (-0.23%)
CELG : 108.24 (+0.10%)
PRTA : 12.41 (+0.65%)
LCI : 8.49 (-1.85%)
Radius (RDUS) Q3 Earnings Beat Estimates on Tymlos Strength

Radius (RDUS) reports a narrower-than-expected loss and beats sales estimates in the third quarter of 2019 as Tymlos gains traction.

LLY : 119.77 (+0.93%)
AMGN : 233.41 (-0.20%)
RDUS : 21.68 (-0.18%)
LCI : 8.49 (-1.85%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Falling.

See More Share

Trade LCI with:

Business Summary

Lannett Company manufactures and distributes high quality affordable generic medications that are the therapeutic equivalent of the brand-name pharmaceuticals. Their portfolio consists of numerous products across a wide range of therapeutic areas. Lannett believes that their ability to select viable...

See More

Key Turning Points

2nd Resistance Point 8.86
1st Resistance Point 8.67
Last Price 8.49
1st Support Level 8.23
2nd Support Level 7.98

See More

52-Week High 15.52
Fibonacci 61.8% 11.25
Fibonacci 50% 9.93
Fibonacci 38.2% 8.60
Last Price 8.49
52-Week Low 4.33

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar